Vaccines, Blood & Biologics
-
?
-
New Drug Application (NDA) Process (CBER)
-
Key Resources
Drug Master Files for CBER-Regulated Products
A Drug Master File (DMF) is a voluntary submission of confidential information to FDA about facilities, manufacturing, processing, packaging, and storing of one or more human drug products.Applications for Approval to Market a New Drug; Complete Response Letter; Amendments to Unapproved Applications 7/10/2008 Questions and Answers Regarding the Complete Response Letter Rule Agency Emergency Processing Under the Office of Management and Budget Review; Certification to Accompany Drug, Biological Product, and Device Applications or Submissions 12/12/2007 Agency Emergency Processing Under the Office of Management and Budget Review; Certification to Accompany Drug, Biological Product, and Device Applications or Submissions; Correction 12/26/2007 Certification of Compliance, under 42 U.S.C. , 282(j)(5)(B), with Requireme (PDF - 406KB)
FDA Form 3674U.S. Food and Drug Administration Statement: The impact of February’s inclement weather on Prescription Drug User Fee Act (PDUFA) and Medical Device User Fee Act (MDUFA) deadlines
-
?
Contact FDA
(800) 835-4709
(301) 827-1800
Consumer Affairs Branch (CBER)
Division of Communication and Consumer Affairs
Office of Communication, Outreach and Development
Food and Drug Administration
1401 Rockville Pike
Suite 200N/HFM-47
Rockville, MD 20852-1448
-
-